FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3093832461> ?p ?o ?g. }

• W3093832461 endingPage "e1498" @default.
• W3093832461 startingPage "e1489" @default.
• W3093832461 abstract "BackgroundNon-communicable diseases (NCDs) cause a large burden of disease globally. Some infectious diseases cause an increased risk of developing specific NCDs. Although the NCD burden from some infectious causes has been quantified, in this study, we aimed to more comprehensively quantify the global burden of NCDs from infectious causes.MethodsIn this modelling study, we identified NCDs with established infectious risk factors and infectious diseases with long-term non-communicable sequelae, and did narrative reviews between April 11, 2018, and June 10, 2020, to obtain relative risks (RRs) or population attributable fractions (PAFs) from studies quantifying the contribution of infectious causes to NCDs. To determine infection-attributable burden for the year 2017, we applied estimates of PAFs to estimates of disease burden from the Global Burden of Disease Study (GBD) 2017 for pairs of infectious causes and NCDs, or used estimates of attributable burden directly from GBD 2017. Morbidity and mortality burden from these conditions was summarised with age-standardised rates of disability-adjusted life-years (DALYs), for geographical regions as defined by the GBD. Estimates of NCD burden attributable to infectious causes were compared with attributable burden for the groups of risk factors with the highest PAFs from GBD 2017.FindingsGlobally, we quantified 130 million DALYs from NCDs attributable to infection, comprising 8·4% of all NCD DALYs. The infection–NCD pairs with the largest burden were gastric cancer due to H pylori (14·6 million DALYs), cirrhosis and other chronic liver diseases due to hepatitis B virus (12·2 million) and hepatitis C virus (10·4 million), liver cancer due to hepatitis B virus (9·4 million), rheumatic heart disease due to streptococcal infection (9·4 million), and cervical cancer due to HPV (8·0 million). Age-standardised rates of infection-attributable NCD burden were highest in Oceania (3564 DALYs per 100 000 of the population) and central sub-Saharan Africa (2988 DALYs per 100 000) followed by the other sub-Saharan African regions, and lowest in Australia and New Zealand (803 DALYs per 100 000) followed by other high-income regions. In sub-Saharan Africa, the proportion of crude NCD burden attributable to infectious causes was 11·7%, which was higher than the proportion of burden attributable to each of several common risk factors of NCDs (tobacco, alcohol use, high systolic blood pressure, dietary risks, high fasting plasma glucose, air pollution, and high LDL cholesterol). In other broad regions, infectious causes ranked between fifth and eighth in terms of crude attributable proportions among the nine risks compared. The age-standardised attributable proportion for infectious risks remained highest in sub-Saharan Africa of the broad regions, but age-standardisation caused infectious risks to fall below dietary risks, high systolic blood pressure, and fasting plasma glucose in ranked attributable proportions within the region.InterpretationInfectious conditions cause substantial NCD burden with clear regional variation, and estimates of this burden are likely to increase as evidence that can be used for quantification expands. To comprehensively avert NCD burden, particularly in low-income and middle-income countries, the availability, coverage, and quality of cost-effective interventions for key infectious conditions need to be strengthened. Efforts to promote universal health coverage must address infectious risks leading to NCDs, particularly in populations with high rates of these infectious conditions, to reduce existing regional disparities in rates of NCD burden.FundingLeona M and Harry B Helmsley Charitable Trust. Non-communicable diseases (NCDs) cause a large burden of disease globally. Some infectious diseases cause an increased risk of developing specific NCDs. Although the NCD burden from some infectious causes has been quantified, in this study, we aimed to more comprehensively quantify the global burden of NCDs from infectious causes. In this modelling study, we identified NCDs with established infectious risk factors and infectious diseases with long-term non-communicable sequelae, and did narrative reviews between April 11, 2018, and June 10, 2020, to obtain relative risks (RRs) or population attributable fractions (PAFs) from studies quantifying the contribution of infectious causes to NCDs. To determine infection-attributable burden for the year 2017, we applied estimates of PAFs to estimates of disease burden from the Global Burden of Disease Study (GBD) 2017 for pairs of infectious causes and NCDs, or used estimates of attributable burden directly from GBD 2017. Morbidity and mortality burden from these conditions was summarised with age-standardised rates of disability-adjusted life-years (DALYs), for geographical regions as defined by the GBD. Estimates of NCD burden attributable to infectious causes were compared with attributable burden for the groups of risk factors with the highest PAFs from GBD 2017. Globally, we quantified 130 million DALYs from NCDs attributable to infection, comprising 8·4% of all NCD DALYs. The infection–NCD pairs with the largest burden were gastric cancer due to H pylori (14·6 million DALYs), cirrhosis and other chronic liver diseases due to hepatitis B virus (12·2 million) and hepatitis C virus (10·4 million), liver cancer due to hepatitis B virus (9·4 million), rheumatic heart disease due to streptococcal infection (9·4 million), and cervical cancer due to HPV (8·0 million). Age-standardised rates of infection-attributable NCD burden were highest in Oceania (3564 DALYs per 100 000 of the population) and central sub-Saharan Africa (2988 DALYs per 100 000) followed by the other sub-Saharan African regions, and lowest in Australia and New Zealand (803 DALYs per 100 000) followed by other high-income regions. In sub-Saharan Africa, the proportion of crude NCD burden attributable to infectious causes was 11·7%, which was higher than the proportion of burden attributable to each of several common risk factors of NCDs (tobacco, alcohol use, high systolic blood pressure, dietary risks, high fasting plasma glucose, air pollution, and high LDL cholesterol). In other broad regions, infectious causes ranked between fifth and eighth in terms of crude attributable proportions among the nine risks compared. The age-standardised attributable proportion for infectious risks remained highest in sub-Saharan Africa of the broad regions, but age-standardisation caused infectious risks to fall below dietary risks, high systolic blood pressure, and fasting plasma glucose in ranked attributable proportions within the region. Infectious conditions cause substantial NCD burden with clear regional variation, and estimates of this burden are likely to increase as evidence that can be used for quantification expands. To comprehensively avert NCD burden, particularly in low-income and middle-income countries, the availability, coverage, and quality of cost-effective interventions for key infectious conditions need to be strengthened. Efforts to promote universal health coverage must address infectious risks leading to NCDs, particularly in populations with high rates of these infectious conditions, to reduce existing regional disparities in rates of NCD burden." @default.
• W3093832461 created "2020-10-29" @default.
• W3093832461 creator A5000030831 @default.
• W3093832461 creator A5003107621 @default.
• W3093832461 creator A5005970027 @default.
• W3093832461 creator A5014144219 @default.
• W3093832461 creator A5029247334 @default.
• W3093832461 creator A5037455328 @default.
• W3093832461 creator A5055956115 @default.
• W3093832461 creator A5058165533 @default.
• W3093832461 creator A5060219200 @default.
• W3093832461 creator A5080730719 @default.
• W3093832461 creator A5090818445 @default.
• W3093832461 date "2020-12-01" @default.
• W3093832461 modified "2023-10-16" @default.
• W3093832461 title "Burden of non-communicable diseases from infectious causes in 2017: a modelling study" @default.
• W3093832461 cites W1962296185 @default.
• W3093832461 cites W1967298458 @default.
• W3093832461 cites W1973531959 @default.
• W3093832461 cites W1993121929 @default.
• W3093832461 cites W2017507345 @default.
• W3093832461 cites W2027013613 @default.
• W3093832461 cites W2032382941 @default.
• W3093832461 cites W2049057420 @default.
• W3093832461 cites W2063396561 @default.
• W3093832461 cites W2069071577 @default.
• W3093832461 cites W2072047081 @default.
• W3093832461 cites W2105654981 @default.
• W3093832461 cites W2110461849 @default.
• W3093832461 cites W2111942462 @default.
• W3093832461 cites W2128855640 @default.
• W3093832461 cites W2140481064 @default.
• W3093832461 cites W2144162491 @default.
• W3093832461 cites W2209941301 @default.
• W3093832461 cites W2411894263 @default.
• W3093832461 cites W2436180963 @default.
• W3093832461 cites W2462340700 @default.
• W3093832461 cites W2472221349 @default.
• W3093832461 cites W2480418585 @default.
• W3093832461 cites W2488426658 @default.
• W3093832461 cites W2520996611 @default.
• W3093832461 cites W2535480840 @default.
• W3093832461 cites W2588372150 @default.
• W3093832461 cites W2605365014 @default.
• W3093832461 cites W2613882035 @default.
• W3093832461 cites W2751792491 @default.
• W3093832461 cites W2753051611 @default.
• W3093832461 cites W2787931223 @default.
• W3093832461 cites W2797413896 @default.
• W3093832461 cites W2883486997 @default.
• W3093832461 cites W2899736836 @default.
• W3093832461 cites W2899773405 @default.
• W3093832461 cites W2909795031 @default.
• W3093832461 cites W2933559208 @default.
• W3093832461 cites W2937883751 @default.
• W3093832461 cites W2954831690 @default.
• W3093832461 cites W2970592424 @default.
• W3093832461 cites W2995167300 @default.
• W3093832461 cites W2999367482 @default.
• W3093832461 cites W3084525766 @default.
• W3093832461 cites W4249723987 @default.
• W3093832461 doi "https://doi.org/10.1016/s2214-109x(20)30358-2" @default.
• W3093832461 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8040338" @default.
• W3093832461 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33098769" @default.
• W3093832461 hasPublicationYear "2020" @default.
• W3093832461 type Work @default.
• W3093832461 sameAs 3093832461 @default.
• W3093832461 citedByCount "54" @default.
• W3093832461 countsByYear W30938324612020 @default.
• W3093832461 countsByYear W30938324612021 @default.
• W3093832461 countsByYear W30938324612022 @default.
• W3093832461 countsByYear W30938324612023 @default.
• W3093832461 crossrefType "journal-article" @default.
• W3093832461 hasAuthorship W3093832461A5000030831 @default.
• W3093832461 hasAuthorship W3093832461A5003107621 @default.
• W3093832461 hasAuthorship W3093832461A5005970027 @default.
• W3093832461 hasAuthorship W3093832461A5014144219 @default.
• W3093832461 hasAuthorship W3093832461A5029247334 @default.
• W3093832461 hasAuthorship W3093832461A5037455328 @default.
• W3093832461 hasAuthorship W3093832461A5055956115 @default.
• W3093832461 hasAuthorship W3093832461A5058165533 @default.
• W3093832461 hasAuthorship W3093832461A5060219200 @default.
• W3093832461 hasAuthorship W3093832461A5080730719 @default.
• W3093832461 hasAuthorship W3093832461A5090818445 @default.
• W3093832461 hasBestOaLocation W30938324611 @default.
• W3093832461 hasConcept C138816342 @default.
• W3093832461 hasConcept C142724271 @default.
• W3093832461 hasConcept C159047783 @default.
• W3093832461 hasConcept C17744445 @default.
• W3093832461 hasConcept C199539241 @default.
• W3093832461 hasConcept C2779473830 @default.
• W3093832461 hasConcept C3018443061 @default.
• W3093832461 hasConcept C71924100 @default.
• W3093832461 hasConcept C99454951 @default.
• W3093832461 hasConceptScore W3093832461C138816342 @default.
• W3093832461 hasConceptScore W3093832461C142724271 @default.
• W3093832461 hasConceptScore W3093832461C159047783 @default.
• W3093832461 hasConceptScore W3093832461C17744445 @default.

• next